Strong Growth Ahead: Biologics Market Projects 8.25% CAGR Increase by 2030

Overview of Biologics Market Size & Future Outlook

According to the latest report by MarkNtel Advisors, the Global Biologics Market size is estimated to grow at a CAGR of around 8.25% from 2025-2030. This report is designed to enhance user understanding and support informed decision-making by thoroughly analyzing key market shifts, identifying gaps, exploring emerging opportunities, and assessing industry trends and competitive challenges. By combining both qualitative and quantitative data, it offers a comprehensive overview, highlighting growth prospects and providing valuable insights into competitors, helping both established companies and new entrants navigate the current market landscape.

If you’re interested in the assumptions considered in this study, you can download the PDF brochure- https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html

What are the key drivers influencing the growth of the Biologics market?

This section provides a detailed analysis of the market drivers and factors is explored thoroughly below.

Increasing Inclination Towards Gene Therapy & Cellular Therapy to Boost the Market Growth – Due to their ability to repair or substitute damaged tissues, gene and cellular treatments have experienced considerable growth in adoption over the historical years. Moreover, the rising investments in research & development of cell and gene therapies have been further bolstering their adoption, owing to the improved efficacy of new drugs. Additionally, there has been increased funding and investments for R&D purposes of cell and gene therapies by companies like Ori Biotech, AstraZeneca Plc, GlaxoSmithKline Biologicals, etc., for the launch of innovative products.

Thus, with enhanced investment, the process of pre-commercialization and market launch has been accelerated, which has been contributing to the market growth. Also, over the historical years, the approvals of these medicines have been accelerated by government organizations like the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), etc. Consequently, as approvals for cell and gene therapies would accelerate in the coming years, it would create an opportunity for their enhanced adoption in the coming years as well.

How is the Biologics market segmented and what are the key factors within each segment?

The Biologics market has been further segmented into distinct categories. Analyzing growth within these segments allows you to identify niche opportunities, develop targeted strategies, and understand the variations in your core application areas and target markets.

By Therapeutic Application

Oncology- Market Size & Forecast 2020-2030, (USD Million)
Infectious Disease- Market Size & Forecast 2020-2030, (USD Million)
Autoimmune Disease- Market Size & Forecast 2020-2030, (USD Million)
Diabetes- Market Size & Forecast 2020-2030, (USD Million)
Cardiovascular Diseases- Market Size & Forecast 2020-2030, (USD Million)
Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)- Market Size & Forecast 2020-2030, (USD Million)

By Drug Class

Recombinant Proteins- Market Size & Forecast 2020-2030, (USD Million)
- Hormones- Market Size & Forecast 2020-2030, (USD Million)
- Cytokines- Market Size & Forecast 2020-2030, (USD Million)
Monoclonal Antibodies- Market Size & Forecast 2020-2030, (USD Million)
Blood & Blood Components- Market Size & Forecast 2020-2030, (USD Million)
Cellular & Gene Therapy- Market Size & Forecast 2020-2030, (USD Million)
Vaccines- Market Size & Forecast 2020-2030, (USD Million)
Others- Market Size & Forecast 2020-2030, (USD Million)

By Source

Microbes- Market Size & Forecast 2020-2030, (USD Million)
Humans- Market Size & Forecast 2020-2030, (USD Million)
Others (Rodents, Plants, etc.)- Market Size & Forecast 2020-2030, (USD Million)

By Region

North America
South America
Europe
The Middle East & Africa
Asia-Pacific.

Browse Full Report Along with TOC and Figures - https://www.marknteladvisors.com/research-library/global-biologics-market.html

Who are the Key Market Players in the Biologics industry?

The competitive landscape of the Biologics market provides a detailed look at the key players in the industry. This includes an overview of each company, their financial performance, revenue generation, and market potential. It also covers their investments in R&D, new market initiatives, production facilities, and strengths and weaknesses. Additionally, the analysis looks at recent product launches, approvals, the range of products offered, their dominance in different applications, and the product life cycle. All of this information is specifically focused on how each company is positioning itself within the market.

Several key players are actively operating in the market, including

Bristol-Myers Squibb
Pfizer
Sanofi
Janssen Biotech, Inc.
Bayer AG
Merck & Co.
Amgen Inc.
Abbott GmbH
Novartis
AstraZeneca Plc
GlaxoSmithKline Biologicals
Moderna, Inc.
Ferring Pharmaceuticals Inc.
Aimmune Therapeutics, Inc.
Hoffman La Roche

Market Advancement by Leading Companies:

2023: Amgen announced the completion of the acquisition of biologics market player, Horizon Therapeutics, which is aligned with its vision for the development of drugs for patients with rare diseases.

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

Other Report:

Why Choose MarkNtel Advisors:

Focused Industry Expertise
Diverse Report Offerings
Personalized Research Solutions
Robust Research Methodology
In-depth Report Coverage
Tracking Technological Advancements
Comprehensive Value-Chain Analysis
Discovering Market Opportunities
Analyzing Growth Trajectories
Assured Quality Insights
Dedicated After-Sales Support
Trusted by Fortune 500 Companies

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Call + +1 628 895 8081, +91 120 4278433

Email: sales@marknteladvisors.com